Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort

被引：0
|
作者：
E. Righi
A. Beltrame
M. Bassetti
V. Lindstrom
G. Mazzarello
C. Dentone
A. Di Biagio
S. Ratto
C. Viscoli
机构：
[1] San Martino University Hospital,Infectious Diseases Dept.
[2] University of Genoa School of Medicine,undefined
来源：
Infection | 2008年 / 36卷
关键词：
Sustained Virological Response; Coinfected Patient; Soriano Versus; Voluntary Interruption;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：358 / 361
页数：3
相关论文
共 50 条
  • [1] Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort
    Righi, E.
    Beltrame, A.
    Bassetti, M.
    Lindstrom, V.
    Mazzarello, G.
    Dentone, C.
    Di Biagio, A.
    Ratto, S.
    Viscoli, C.
    INFECTION, 2008, 36 (04) : 358 - 361
  • [2] Therapeutical aspects and predictors of outcome for HIV/HCV co-infected patients treated with pegylated interferon plus ribavirin. Survey in an Italian university hospital
    Righi, E.
    Bassetti, M.
    Di Biagio, A.
    Dentone, C.
    Rosso, R.
    Beltrame, A.
    Mazzarello, G.
    Ratto, S.
    Viscoli, C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S543 - S543
  • [3] Hcv dynamics in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin.
    Talal, AH
    Shata, MT
    Flynn, SM
    Dorante, G
    Laughlin, M
    Ribeiro, RM
    Perelson, AS
    HEPATOLOGY, 2002, 36 (04) : 205A - 205A
  • [4] Incidence and consequences of thrombocytopenia in 1523 HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin
    Cattelan, Anna Maria
    Bruno, Raffaele
    Cariti, Giuseppe
    Carosi, Giampiero
    Angeli, Elena
    Pontali, Emanuele
    Gulminetti, Roberto
    Maida, Ivana
    Nasta, Paola
    Verucchi, Gabriella
    Caputo, Antonietta
    Iannacone, Claudio
    Puoti, Massimo
    HEPATOLOGY, 2012, 56 : 1021A - 1022A
  • [5] IL23 PROMOTES INTERFERON RESPONSIVENESS IN HIV/HCV COINFECTED PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Odigie, Madeline
    Zhang, Xiaozhen
    Masur, Henry
    Polis, Michael A.
    Kottilil, Shyam
    Osinusi, Anu
    HEPATOLOGY, 2011, 54 : 488A - 488A
  • [6] Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
    Nunez, M.
    Ocampo, A.
    Aguirrebengoa, K.
    Cervantes, M.
    Pascual, A.
    Echeverria, S.
    Asensi, V.
    Barreiro, P.
    Garcia-Samaniego, J.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (05) : 363 - 369
  • [7] Early HCV-RNA clearance in HIV/HCV-coinfected patients treated with pegylated interferon alfa-2a plus ribavirin
    Camino, N
    Nuñez, M
    Romero, M
    Barreiro, P
    Ocampo, A
    Miralles, C
    Martín-Carbonero, L
    Fernández, A
    García-Samaniego, J
    Soriano, V
    HEPATOLOGY, 2004, 40 (04) : 402A - 403A
  • [8] Incidence, predictors and management strategies of anemia in HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin
    Angeli, Elena
    Bruno, Raffaele
    Cariti, Giuseppe
    Carosi, Giampiero
    Pontali, Emanuele
    Cattelan, Anna Maria
    Gulminetti, Roberto
    Maida, Ivana
    Nasta, Paola
    Verucchi, Gabriella
    Caputo, Antonietta
    Iannacone, Claudio
    Puoti, Massimo
    HEPATOLOGY, 2012, 56 : 1021A - 1021A
  • [9] Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
    Kovari, Helen
    Russmann, Stefan
    Ledergerber, Bruno
    Mueller, Daniel
    Rotger, Margalida
    Velli, Pablo
    Cavassini, Matthias
    Ambrosioni, Juan
    Bregenzer, Andrea
    Stoeckle, Marcel
    Bernasconi, Enos
    Rauch, Andri
    Speck, Roberto F.
    PLOS ONE, 2015, 10 (07):
  • [10] Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients
    Mira, Jose A.
    Lopez-Cortes, Luis F.
    Merino, Dolores
    Arizcorreta-Yarza, Ana
    Rivero, Antonio
    Collado, Antonio
    Rios-Villegas, Maria J.
    Gonzalez-Serrano, Mercedes
    Torres-Tortosa, Manuel
    Macias, Juan
    Valera-Bestard, Barbara
    Fernandez-Fuertes, Elisa
    Giron-Gonzalez, Jose A.
    Lozano, Fernando
    Pineda, Juan A.
    ANTIVIRAL THERAPY, 2007, 12 (08) : 1225 - 1235
12345